沪深交易所月内受理15宗IPO

Core Viewpoint - The IPO acceptance process is accelerating as the year-end approaches, with a total of 19 IPO applications accepted in December, primarily by the Shanghai and Shenzhen stock exchanges, indicating a robust growth in the A-share market for new listings in 2025 [1][3][9]. Group 1: IPO Acceptance and Market Trends - From December 22 to 24, seven companies, including Boma Medical and Siyi Technology, had their IPO applications accepted, with the Shanghai Stock Exchange accepting three and the Shenzhen Stock Exchange four [3]. - As of December 24, the total number of IPOs accepted in December reached 19, with the Shanghai and Shenzhen exchanges accounting for nearly 80% of these [1][3]. - The A-share market is expected to see 114 new IPOs in 2025, representing a 14% increase compared to the previous year [1][9]. Group 2: Company Specifics and Financials - Among the newly accepted IPOs, four companies, including Yuanchip Semiconductor and Guoyi Quantum, are notable for their high-tech focus and are applying for listings despite reporting losses [6][7]. - Yuanchip Semiconductor aims to raise approximately 7.5 billion yuan, making it the largest fundraising among the new IPOs [4][6]. - Other companies with proposed fundraising over 1 billion yuan include Xinowei and Boma Medical, with Xinowei's fundraising amounting to 2.94 billion yuan [4]. Group 3: Market Dynamics and Future Outlook - The acceptance of IPOs from unprofitable companies is seen as a way to enrich the market structure and provide high-growth investment opportunities [7]. - The overall fundraising amount from new IPOs this year has significantly increased, with 111 new stocks raising approximately 125.32 billion yuan, compared to 67.35 billion yuan last year [9][10]. - Deloitte's report anticipates that by the end of 2025, the A-share market will see 114 companies listed, raising 129.6 billion yuan, with a focus on sectors prioritized in China's development plans [10][11].